QQ客服 官方微博 反馈留言

	Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer
	Shen, Yan-Wei; Zhang, Xiao-Man; Li, Shu-Ting; Lv, Meng; Yang, Jiao; Wang, Fan; Chen, Zhe-Ling; Wang, Bi-Yuan; Li, Pan; Chen, Ling
刊名	ONCOTARGETS AND THERAPY
	2016
卷号	9期号:[db:dc_citation_issue]页码:929-935
关键词	icotinib hydrochloride lung neoplasms first-line treatment
ISSN号	1178-6930
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3225406
专题	西安交通大学
推荐引用方式 GB/T 7714	Shen, Yan-Wei,Zhang, Xiao-Man,Li, Shu-Ting,et al. Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer[J]. ONCOTARGETS AND THERAPY,2016,9([db:dc_citation_issue]):929-935.
APA	Shen, Yan-Wei.,Zhang, Xiao-Man.,Li, Shu-Ting.,Lv, Meng.,Yang, Jiao.,...&Yang, Jin.(2016).Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer.ONCOTARGETS AND THERAPY,9([db:dc_citation_issue]),929-935.
MLA	Shen, Yan-Wei,et al."Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer".ONCOTARGETS AND THERAPY 9.[db:dc_citation_issue](2016):929-935.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。